Clinical Trial Update: Bromocriptine and Pentoxifylline in Ophthalmopathy Autoimmune Treatment [NA]

View source ↗

Summary

A clinical trial evaluating bromocriptine and pentoxifylline for Graves' ophthalmopathy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Ophthalmopathy

Drugs mentioned

• Bromocriptine (bromocriptine)
• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Conditions: Graves Ophthalmopathy | NA | Status: TERMINATED